Systematizing serendipity for cardiovascular drug discovery.
作者信息
Schlueter Peter J, Peterson Randall T
机构信息
Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
出版信息
Circulation. 2009 Jul 21;120(3):255-63. doi: 10.1161/CIRCULATIONAHA.108.824177.
Abstract
摘要
相似文献
1
Systematizing serendipity for cardiovascular drug discovery.为心血管药物研发将意外发现系统化。
Circulation. 2009 Jul 21;120(3):255-63. doi: 10.1161/CIRCULATIONAHA.108.824177.
2
Cardiovascular pharmacology in the post-blockbuster era.重磅炸弹药物时代后的心血管药理学
Curr Opin Pharmacol. 2010 Apr;10(2):109-10. doi: 10.1016/j.coph.2010.02.004. Epub 2010 Mar 2.
3
Challenges in the Development of Novel Cardiovascular Therapies.新型心血管疗法研发中的挑战
Clin Pharmacol Ther. 2017 Aug;102(2):194-196. doi: 10.1002/cpt.703. Epub 2017 Jun 23.
4
Occlusion in the Flow of New Drugs for Cardiovascular Disease.心血管疾病新药研发受阻。
Clin Pharmacol Ther. 2017 Aug;102(2):246-253. doi: 10.1002/cpt.691. Epub 2017 Jun 5.
5
Cardiovascular pipeline decline quantified.心血管管道衰退量化。
Nat Rev Drug Discov. 2016 Sep 29;15(10):669. doi: 10.1038/nrd.2016.208.
6
The Future of Cardiovascular Therapeutics.心血管治疗的未来
Circulation. 2016 Jun 21;133(25):2610-7. doi: 10.1161/CIRCULATIONAHA.116.023555.
7
Vascular science: A glimpse into the future.血管科学：展望未来
J Vasc Surg. 2018 Dec;68(6S):1S-2S. doi: 10.1016/j.jvs.2018.10.045.
8
Drug development research: diabetes favored over cardiovascular disease?药物研发研究：糖尿病比心血管疾病更受青睐？
Curr Opin Investig Drugs. 2009 Mar;10(3):217-9.
9
Applications of 'decisionable' biomarkers in cardiovascular drug development.“决策性”生物标志物在心血管药物研发中的应用。
Biomark Med. 2010 Dec;4(6):815-27. doi: 10.2217/bmm.10.107.
10
Innovations driving biomarker evaluation and use.推动生物标志物评估与应用的创新。
Biomark Med. 2010 Dec;4(6):779-81. doi: 10.2217/bmm.10.114.
引用本文的文献
1
Systematized Serendipity: Fishing Expeditions for Anesthetic Drugs and Targets.系统化的机缘巧合：麻醉药物和靶点的探索性研究。
Anesthesiology. 2024 Nov 1;141(5):997-1006. doi: 10.1097/ALN.0000000000005153.
2
Antiviral alternatives against important members of the subfamily Parvovirinae: a review.抗细小病毒亚科重要成员的抗病毒替代物：综述。
Arch Virol. 2024 Feb 20;169(3):52. doi: 10.1007/s00705-024-05995-8.
3
Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease.基于RNA的疗法在心血管疾病中的应用与潜力
JACC Basic Transl Sci. 2022 Jun 8;7(9):956-969. doi: 10.1016/j.jacbts.2022.02.003. eCollection 2022 Sep.
4
Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates.曲普瑞林是一种可在雄性小鼠和非人类灵长类动物中可逆的非激素男性避孕药。
Nat Commun. 2021 Feb 23;12(1):1253. doi: 10.1038/s41467-021-21517-5.
5
BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database.BRCA-Monet：一种利用大规模微阵列数据库进行治疗效果预测的乳腺癌特异性药物治疗作用机制网络。
BMC Syst Biol. 2013;7 Suppl 5(Suppl 5):S5. doi: 10.1186/1752-0509-7-S5-S5. Epub 2013 Dec 9.
6
In vivo chemical screening for modulators of hematopoiesis and hematological diseases.针对造血和血液疾病调节剂的体内化学筛选。
Adv Hematol. 2012;2012:851674. doi: 10.1155/2012/851674. Epub 2012 Jun 19.
7
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling.体内利钠肽报告基因检测法鉴定肥厚型心肌病信号转导的化学修饰物。
Cardiovasc Res. 2012 Mar 1;93(3):463-70. doi: 10.1093/cvr/cvr350. Epub 2011 Dec 23.
8
Drug discovery in a multidimensional world: systems, patterns, and networks.多维世界中的药物发现：系统、模式和网络。
J Cardiovasc Transl Res. 2010 Oct;3(5):438-47. doi: 10.1007/s12265-010-9214-6. Epub 2010 Jul 31.
9
Targeting the undruggable proteome: the small molecules of my dreams.靶向不可成药蛋白质组：我梦想中的小分子。
Chem Biol. 2010 Jun 25;17(6):551-5. doi: 10.1016/j.chembiol.2010.05.011.
10
Traversing the valley of death: a guide to assessing prospects for translational success.穿越死亡之谷：评估转化成功前景的指南。
Sci Transl Med. 2009 Dec 9;1(10):10cm9. doi: 10.1126/scitranslmed.3000265.
本文引用的文献
1
Identifying the proteins to which small-molecule probes and drugs bind in cells.确定小分子探针和药物在细胞中所结合的蛋白质。
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4617-22. doi: 10.1073/pnas.0900191106. Epub 2009 Mar 2.
2
Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN).利用寡聚体库工程（OPEN）技术制备的锌指核酸酶对内源斑马鱼基因进行快速突变。
PLoS One. 2009;4(2):e4348. doi: 10.1371/journal.pone.0004348. Epub 2009 Feb 9.
3
Chemical biology and the limits of reductionism.化学生物学与还原论的局限
Nat Chem Biol. 2008 Nov;4(11):635-8. doi: 10.1038/nchembio1108-635.
4
SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function.用于定量蛋白质组学的稳定同位素标记氨基酸细胞培养小鼠模型揭示了纽带蛋白-3是红细胞功能的关键因子。
Cell. 2008 Jul 25;134(2):353-64. doi: 10.1016/j.cell.2008.05.033.
5
An integrated platform of genomic assays reveals small-molecule bioactivities.一个基因组分析的综合平台揭示了小分子生物活性。
Nat Chem Biol. 2008 Aug;4(8):498-506. doi: 10.1038/nchembio.100. Epub 2008 Jul 11.
6
Comparative phosphoproteomics of zebrafish Fyn/Yes morpholino knockdown embryos.斑马鱼Fyn/Yes吗啉代寡核苷酸敲低胚胎的比较磷酸化蛋白质组学
Mol Cell Proteomics. 2008 Nov;7(11):2176-87. doi: 10.1074/mcp.M800081-MCP200. Epub 2008 Jun 11.
7
Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases.利用工程化锌指核酸酶在斑马鱼中进行靶向基因失活。
Nat Biotechnol. 2008 Jun;26(6):695-701. doi: 10.1038/nbt1398. Epub 2008 May 25.
8
Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases.利用设计的锌指核酸酶在斑马鱼中进行可遗传的靶向基因破坏。
Nat Biotechnol. 2008 Jun;26(6):702-8. doi: 10.1038/nbt1409. Epub 2008 May 25.
9
Targeted gene expression by the Gal4-UAS system in zebrafish.Gal4-UAS系统在斑马鱼中的靶向基因表达。
Dev Growth Differ. 2008 Aug;50(6):391-9. doi: 10.1111/j.1440-169X.2008.01044.x. Epub 2008 May 14.
10
Cardiogenic small molecules that enhance myocardial repair by stem cells.通过干细胞增强心肌修复的心脏源性小分子。
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6063-8. doi: 10.1073/pnas.0711507105. Epub 2008 Apr 17.
Zotero 插件